Completed NA INTERVENTIONAL 2-arm NCT03960216

Effects of Periodontal Therapy in Patients With Metabolic Syndrome (MetS)

Effects of Periodontal Therapy on Local and Systemic Markers of Inflammation in Patients With Metabolic Syndrome

Sponsor: Colgate Palmolive

Conditions Metabolic Syndrome Periodontitis

Interventions Scaling and root planning Supragingival Prophylaxis

Updated 4 times since 2019 Last updated: May 23, 2019 Started: Nov 28, 2012 Primary completion: May 30, 2013 Completion: Jul 2, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Metabolic Syndrome and Periodontitis and is currently completed. Colgate Palmolive leads this study, which shows 4 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2019 — Jan 2021 [monthly]

Completed NA

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Colgate Palmolive
Universidad Complutense de Madrid

Data source: Universidad Complutense de Madrid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.